Edwards Kimberly R, Mowad Christen M, Tyler William B
Department of Dermatology, Geisinger Medical Center, 100 N. Academy Avenue, Danville, PA 17821, USA.
J Drugs Dermatol. 2003 Apr;2(2):184-7.
We report the case of a patient with persistent and worsening injection site reactions associated with subcutaneous etanercept therapy. Injection site reactions are well documented to occur early in therapy; however they typically decrease in frequency over time. This patient developed early injection site reactions that have persisted and worsened into his tenth month of treatment with etanercept.